Evolent Health (EVH) Liabilities and Shareholders Equity (2014 - 2026)

Evolent Health's Liabilities and Shareholders Equity history runs 13 years deep, the most recent figure standing at $1.9 billion for Q1 2026.

• On a quarterly basis, Liabilities and Shareholders Equity fell 29.19% year-over-year to $1.9 billion in Q1 2026; TTM through Mar 2026 was $8.7 billion, a 14.56% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, down 25.36% from the prior year.
• Liabilities and Shareholders Equity declined to $1.9 billion in Q1 2026 per EVH's latest filing, from $1.9 billion in the prior quarter.
• Across five years, Liabilities and Shareholders Equity topped out at $2.7 billion in Q4 2023 and bottomed at $1.3 billion in Q2 2022.
• The 5-year median for Liabilities and Shareholders Equity is $2.5 billion (2024), against an average of $2.3 billion.
• Across the five-year window, Liabilities and Shareholders Equity surged 102.99% in 2023 and decreased 29.19% in 2026, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $1.8 billion in 2022, then soared by 47.49% to $2.7 billion in 2023, then slipped by 5.07% to $2.5 billion in 2024, then fell by 25.36% to $1.9 billion in 2025, then retreated by 1.07% to $1.9 billion in 2026.
• Per Business Quant, the three latest EVH Liabilities and Shareholders Equity figures stand at $1.9 billion (Q1 2026), $1.9 billion (Q4 2025), and $2.5 billion (Q3 2025).